PLEKHA9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.152600E-01
Normal-vs-Stage2
6.853000E-01
Normal-vs-Stage3
2.523800E-01
Normal-vs-Stage4
1.241840E-01
Stage1-vs-Stage2
3.624200E-01
Stage1-vs-Stage3
8.114000E-01
Stage1-vs-Stage4
4.370400E-01
Stage2-vs-Stage3
2.811000E-01
Stage2-vs-Stage4
6.550400E-02
Stage3-vs-Stage4
5.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.270400E-01
Normal-vs-AfricanAmerican
6.957400E-01
Normal-vs-Asian
7.204600E-01
Caucasian-vs-AfricanAmerican
1.426970E-01
Caucasian-vs-Asian
5.665800E-01
AfricanAmerican-vs-Asian
3.370800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.677000E-01
Normal-vs-Female
2.473000E-01
Male-vs-Female
2.764000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.443800E-01
Normal-vs-Age(41-60Yrs)
9.842000E-01
Normal-vs-Age(61-80Yrs)
3.683600E-01
Normal-vs-Age(81-100Yrs)
4.194400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.155800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.109400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.234400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.981700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.690200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.953400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.092800E-01
Normal-vs-Daily Drinker
9.574200E-02
Normal-vs-Weekly Drinker
3.300600E-01
Normal-vs-Occasional Drinker
3.496400E-01
Normal-vs-Social Drinker
9.499200E-01
Non Drinker-vs-Daily Drinker
1.496000E-01
Non Drinker-vs-Weekly Drinker
8.443000E-01
Non Drinker-vs-Occasional Drinker
8.402600E-01
Non Drinker-vs-Social Drinker
5.384200E-02
Daily Drinker-vs-Weekly Drinker
3.354200E-01
Daily Drinker-vs-Occasional Drinker
3.180200E-01
Daily Drinker-vs-Social Drinker
4.338500E-03
Weekly Drinker-vs-Occasional Drinker
9.973000E-01
Weekly Drinker-vs-Social Drinker
9.348000E-02
Occasional Drinker-vs-Social Drinker
8.359800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.411800E-01
Normal-vs-Grade 2
8.868800E-01
Normal-vs-Grade 3
8.895600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.653700E-02
Grade 1-vs-Grade 3
1.379010E-01
Grade 1-vs-Grade 4
9.411800E-01
Grade 2-vs-Grade 3
9.644400E-01
Grade 2-vs-Grade 4
8.868800E-01
Grade 3-vs-Grade 4
8.895600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.650600E-01
Normal-vs-NonDiabetic
6.023600E-01
Diabetic-vs-NonDiabetic
2.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.791400E-01
Normal-vs-NoPancreatitis
5.167400E-01
Pancreatitis-vs-NoPancreatitis
3.820000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.931600E-01
Normal-vs-N1
6.977000E-01
N0-vs-N1
5.228400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.352200E-01
Normal-vs-TP53-NonMutant
3.511000E-01
TP53-Mutant-vs-TP53-NonMutant
9.962600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
